MedTrace Logo

Male Circumcision (MC) Using the ShangRing™ Device in Malawi

NCT02309710 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2016-01-21

No results posted yet for this study

Summary

This prospective study will evaluate the safety and acceptability of the ShangRing device for medical male circumcision (MMC) during routine service delivery in Namitete, Malawi

Conditions

  • Male Circumcision

Interventions

DEVICE

ShangRing

ShangRing administered to males seeking medical male circumcision

Sponsors & Collaborators

  • FHI 360

    lead OTHER

Principal Investigators

  • Paul Feldblum, Ph.D. · FHI 360

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Malawi

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02309710 on ClinicalTrials.gov